Evaluation of in vivo cerebral metabolism on proton magnetic resonance spectroscopy in patients with impaired glucose tolerance and type 2 diabetes mellitus

Journal of Diabetes and its Complications

Volumn 22, Issue 4, 2008, Pages 254-260

  Sahin, Ibrahim ^a   Alkan, Alpay ^a   Keskin, Lezzan ^a   Cikim, Ayse ^a   Karakas, Hakki M ^a   Firat, Ahmet K ^a   Sigirci, Ahmet ^a  

^a Inonu School of Medicine   (Turkey)

Author keywords

Brain; Diabetes; Impaired glucose tolerance; Magnetic resonance spectroscopy

Indexed keywords

CHOLINE; CREATINE; HEMOGLOBIN A1C; INOSITOL; N ACETYLASPARTIC ACID;

ADULT; ARTICLE; BRAIN METABOLISM; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; FEMALE; FRONTAL CORTEX; GLYCEMIC CONTROL; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; MALE; NERVE CELL LESION; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; STATISTICAL ANALYSIS; THALAMUS; VOLUNTEER; WHITE MATTER;

ADULT; AGED; ASPARTIC ACID; CEREBRAL CORTEX; CHOLINE; CREATINE; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMANS; INOSITOL; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED;

EID: 45849119076     PISSN: 10568727     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdiacomp.2007.03.007     Document Type: Article

References (29)

1. Alkan A., Kutlu R., Hallac T., Sigirci A., Emul M., Pala N., et al. Occupational prolonged organic solvent exposure in shoemakers: Brain MR spectroscopy findings. Magnetic Resonance Imaging 22 (2004) 707-713
2. Alkan A., Kutlu R., Kocak G., Sigirci A., Emul M., Dogan S., et al. Brain MR spectroscopy in children with a history of rheumatic fever with a special emphasis on neuropsychiatric complications. European Journal of Radiology 49 (2004) 224-228
3. Alkan A., Sarac K., Kutlu R., Yakinci C., Sigirci A., Aslan M., et al. Proton MR spectroscopy features of normal appearing white matter in neurofibromatosis type 1. Magnetic Resonance Imaging 21 (2003) 1049-1053
4. Araki Y., Nomura M., Tanaka H., Yamamoto H., Yamamoto T., Tsukaguchi I., et al. MRI of the brain in diabetes mellitus. Neuroradiaology 36 (1994) 101-103
5. Barba I., Moreno A., Martinez-Perez I., Tate A.R., Cabanas M.E., Baquero M., Capdevila A., and Arús C. Magnetic resonance spectroscopy of brain hemangiopericytomas: High myoinositol concentrations and discrimination from meningiomas. Journal of Neurosurgery 94 (2001) 55-60
6. Biessels G.J., Braun K.P., de Graaf R.A., van Eijsden P., Gispen W.H., and Nicolay K. Cerebral metabolism in streptozotocin-diabetic rats: An in vivo magnetic resonance spectroscopy study. Diabetologia 44 (2001) 346-353
7. Biessels G.J., Kappelle A.C., Bravenboer B., Erkelens D.W., and Gispen W.H. Cerebral function in diabetes mellitus. Diabetologia 37 (1994) 643-650
8. Biessels G.J., van der Heide L.P., Kamal A., Bleys R.L., and Gispen W.H. Ageing and diabetes: Implications for brain function. Eurpean Journal of Pharmacology 441 (2002) 1-14
9. Bitsch, Bruhn H., Vougioukas V., Stringaris A., Lassmann H., Frahm J., et al. Inflammatory CNS demyelination: Histopathologic with in vivo quantitative proton MR spectroscopy. AJNR American Journal of Neuroradiology 20 (1999) 1619-1627
10. Brands A.M., Henselmans J.M., Haan E.H., and Biessels G.J. Diabetic encephalopathy: An underexposed complication of diabetes mellitus. Nederlands Tijdschrift voor Geneeskunde 147 1 (2003) 11-14
11. Brands A.M., Kessels R.P., de Haan E.H., Kappelle L.J., and Biessels G.J. Cerebral dysfunction in type 1 diabetes: Effects of insulin, vascular risk factors and blood-glucose levels. Eurpean Journal of Pharmacology 490 (2004) 159-168
12. Cecil K.M., and Jones B.V. Magnetic resonance spectroscopy of pediatric brain. Topics Magnetic Resonance Imaging 12 (2001) 435-452
13. Dejgaard A., Gade A., Larsso H., Balle V., Parving A., and Parving H.H. Evidence for diabetic encephalopathy. Diabetic Medicine 8 (1991) 162-167
14. Ernst T., and Hennig J. Coupling effects in volume selective 1H spectroscopy of major brain metabolites. Magnetic Resonance Medicine 21 (1991) 82-96
15. Ernst T., Kreis R., and Ross B.D. Absolute quantitation of water and metabolites in the human brain. I. Compartments and water. Journal of Magnetic Resonance 102 (1993) 1-8
16. Govindaraju V., Young K., and Maudsley A.A. Proton NMR chemical shifts and coupling constants for brain metabolites. NMR in Biomedicine 13 (2000) 129-153
17. Kreis R., and Ross B.D. Cerebral metabolic disturbances in patients with subacute and chronic diabetes mellitus: Detection with proton MR spectroscopy. Radiology 184 (1992) 123-130
18. Kumar J.S., and Menon V.P. Effect of diabetes on levels of lipid peroxides and glycolipids in rat brain. Metabolism 42 (1993) 1435-1439
19. Lai P.H., Chen P.C., Chang M.H., Pan H.B., Yang C.F., Wu MT., et al. In vivo proton MR spectroscopy of chorea-ballismus in diabetes mellitus. Neuroradiology 43 (2001) 525-531
20. Makimattila S., Malmberg-Ceder K., Hakkinen A.M., Vuori K., Salonen O., Summanen P., et al. Brain metabolic alterations in patients with type 1 diabetes-hyperglycemia-induced injury. Journal of Cerebral Blood Flow and Metabolism 24 (2004) 1393-1399
21. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., and Turner R.C. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985) 412-419
22. Perros P., Deary I.J., Sellar R.J., Best J.J., and Frier B.M. Brain abnormalities demonstrated by magnetic resonance imaging in adult IDDM patients with and without a history of recurrent severe hypoglycemia. Diabetes Care 20 (1997) 1013-1018
23. Ross B., and Michaelis T. Clinical applications of magnetic resonance spectroscopy. Magnetic Resonance Quarterly 10 (1994) 191-247
24. Sarac K., Akinci A., Alkan A., Aslan M., Baysal T., and Ozcan C. Brain metabolite changes on proton magnetic resonance spectroscopy in children with poorly controlled type 1 diabetes mellitus. Neuroradiology 47 (2005) 562-565
25. Tallroth G., Ryding E., and Agardh C.D. The influence of hypoglycaemia on regional cerebral blood volume in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 36 (1993) 530-535
26. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20 (1997) 1183-1197
27. Tun P.A., Nathan D.M., and Perlmuter L.C. Cognitive and affective disorders in elderly diabetics. Clinics in Geriatric Medicine 13 (1990) 741-754
28. Vincent A.M., Brownlee M., and Russell J.W. Oxidative stress and programmed cell death in diabetic neuropathy. Annals of the New York Academy of Sciences 959 (2002) 368-383
29. Winegrad, A.I., Greene, D.A. Diabetic polyneuropathy: The importance of insulin deficiency, hyperglycemia and alterations in myoinositol metabolism in its pathogenesis. New England Journal of Medicine, 295, 1416-1421.